• Search
  • Helpdesk
  • Sales contact

Decentralized trials: keys to achieving success

Last updated: August 6, 2024

What extra considerations are required for successfully implementing Decentralized Clinical Trials (DCTs) in addition to those for traditional site-based trials?

In this interview, Estelle Haenel, Chief Medical Officer at Kayentis, shares valuable insights on how to select a DCT strategy and ensure that DCTs remain patient-focused.

Check out the “Clinical Trial Chronicles” podcast on Spotify for more insights on clinical trials!

Meet us at the following events

Rethinking Phase 1 Oncology Trials with Electronic Patient-Reported Outcomes

November 4 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
The primary aim of Phase 1 oncology clinical trials is to determine the safety of a new treatment, and to...